ArticleJournal of breast cancer2024

The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients.

Liangqiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.